Christie Hospital

Manchester, England M20 4BX

0 studies enrolling now · 4 studies all time

What they study most

Borderline Ovarian Serous Tumor, Childhood Teratoma, Choriocarcinoma, Extragonadal Seminoma, Germ Cell Tumor, Germinoma, Malignant Germ Cell Neoplasm, Metastatic Pancreatic Adenocarcinoma, Micropapillary Serous Carcinoma, Mixed Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Serous Adenocarcinoma

Studies at this site

• Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer — Completed
• Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors — Running, not enrolling
• Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery — Stopped early
• A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) — Completed